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A Connective Tissue Disorder Caused
by Mutations of the Lysyl Hydroxylase 3 Gene
Antti M. Salo,1 Helen Cox,2 Peter Farndon,2 Celia Moss,3 Helen Grindulis,4 Maija Risteli,1
Simon P. Robins,5 and Raili Myllyla¨1,*
Lysyl hydroxylase 3 (LH3, encoded by PLOD3) is a multifunctional enzyme capable of catalyzing hydroxylation of lysyl residues and
O-glycosylation of hydroxylysyl residues producing either monosaccharide (Gal) or disaccharide (Glc-Gal) derivatives, reactions that form
part of the many posttranslational modiﬁcations required during collagen biosynthesis. Animal studies have conﬁrmed the importance
of LH3, particularly in biosynthesis of the highly glycosylated type IV and VI collagens, but to date, the functional signiﬁcance in vivo of
this enzyme in man is predominantly unknown. We report here a human disorder of LH3 presenting as a compound heterozygote with
recessive inheritance. One mutation dramatically reduced the sugar-transfer activity of LH3, whereas another abrogated lysyl hydroxy-
lase activity; these changes were accompanied by reduced LH3 protein levels in cells. The disorder has a unique phenotype causing
severe morbidity as a result of features that overlap with a number of known collagen disorders.Lysyl hydroxylase (LH, E.C. 1.14.11.4), a member of the
2-oxoglutarate-dependent dioxygenase family, is an enzyme
modifying lysyl residues in collagens,1,2 highly specialized
proteins universally distributed in human body. LH has
three isoforms (LH1, LH2, and LH3) with LH activity char-
acterized in various tissues of higher species.3 In addition
to lysyl hydroxylase activity,4,5 LH3 (encoded by PLOD3)
has also collagen galactosyltransferase6 (GT, E.C. 2.4.1.50)
and glucosyltransferase7,8 (GGT, E.C. 2.4.1.66) activities
in vitro and in vivo.9,10 The multifunctionality of LH3 dis-
tinguishes it from the other LH isoforms. LH3 is evolution-
arily the oldest of the LH isoforms,11 and this ancestral gene
in lower-level species such as C. elegans is also multifunc-
tional.3,6,8 LH3 is found in serum and in tissues, where
this enzyme is also detected in extracellular space.12 Our
recent data reveal the importance of extracellular LH3 in
cell growth10 in vitro, but the in vivo function of LH3 in
the extracellular space remains to be elucidated. LH iso-
forms have no strict sequence speciﬁcity, but there is a clear
preference for some sequences to be bound and hydroxyl-
ated by certain isoforms in vitro.13 LH1 and LH3 have
been shown to be responsible for hydroxylation of lysines
destined for the triple helical region of collagens, and LH2
has been shown to function as a telopeptide lysyl hydroxy-
lase.14–16 Our data suggest that LH3 is particularly responsi-
ble for hydroxylation of lysine residues in which hydroxy-
lysines are further glycosylated.17
Analyses of the pyridiniumcrosslinks of collagen in urine
provide a usefulmethod of detecting certain connective tis-
sue disorders. During suchmonitoring, we detected one pa-
tient lacking the disaccharide derivative of pyridinoline
(Glc-Gal-PYD), a component that in normal urine com-
prises ~15% of free pyridinoline crosslinks:18 There was
no compensatory increase in the monosaccharide deriva-tive,Gal-PYD(Figure1). Further analysisof theurine sample
also revealed abnormalities in hydroxylysine glycosides
with a decreased ratio of disaccharide to monosaccharide
(0.8) compared with that for two age-matched controls
(1.3). The measured total hydroxyproline concentration
in theurinewaswithin thenormal rangeat287mmol/mmol
creatinine. The lack of glycosylated collagen crosslinks in
thepatient’s urine suggested adefect of the enzymeglycosy-
lating hydroxylysine residues, for which LH3was the prime
candidate. The suggestionwas supported by our recent data
from LH3-manipulated mouse lines9 revealing that LH3 is
most likely to be solely responsible for GGT activity in
mouse embryos. Our results also indicated that GGT activ-
ity correlated with the amount of LH3 in mouse tissues.12
In addition, the recent data17 from LH3-knockout embry-
onic ﬁbroblasts indicated a smaller molecular size of types
I, IV, and VI collagens in immunoblot analysis; such a
ﬁnding suggests a loss of hydroxylysine glycosylations in
polypeptides and thus conﬁrms the role of LH3 in hydrox-
ylysine glycosylation.
The proband is female and the fourth liveborn infant of
ahealthy, nonconsanguineous coupleof Europeandescent.
Pregnancywas complicated by intrauterine growth retarda-
tion (IUGR). Delivery was at 40 weeks, gestation and the in-
fant was small for dates at 1.95 Kg (<0.3rd centile). Length
and head circumference were also <0.3rd centile. Postna-
tally, growth continued below2 standard deviations. Cra-
niofacial characteristics included shallow orbits, a small
nose, downturned corners of the mouth, low-set ears, and
a generally ﬂat facial proﬁle (Figures 2A–2C). A right-sided
diaphragmatic eventration was repaired when the patient
was5monthsof age. Thediaphragmwasnoted tobe friable;
the initial repair failed and a second surgical repair was
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equinovarus requiring surgical correction and ﬂexion con-
tractures at the proximal interphalangeal joints of the ﬁrst,
second, and third ﬁngers. Knee joints appeared prominent.
Scoliosis progressed from age 7 of the patient. No underly-
ing vertebral malformations were found on X-rays. Platy-
spondyly with inferior beaking of the second lumbar verte-
bra, small capital femoral epiphyses, a J-shaped sella turcica,
and small odontoid were noted, but no unifying diagnosis
that could explain these featureswas suggested.Osteopenia
and healed fractures of the left clavicle, right femur, and
right humerus were seen. Skeletal muscle bulk was poor,
but no investigations of muscle function were clinically
indicated. Profound bilateral sensorineural deafness (no
responses at >100 dB on brain-stem evoked responses)
was treated with cochlear implantation. Visual acuities
Figure 1. Collagen Crosslink Analysis
Patterns of collagen-derived pyridinium crosslinks in unhydrolyzed
urine from (A) proband and (B) age-matched healthy control,
analyzed as described previously.26 Hydroxylysine glycosides
were analyzed by LC/MS/MS with multiple reaction monitoring27
with a ABI QTRAP 3200 instrument. After prefractionation of urines
by partition chromatography on cellulose columns, the crosslink
components were separated by RP-HPLC and quantified by their
natural fluorescence (ex. 295: emm 400 nm) in relation to an inter-
nal standard (IS), O-acetyl-pyridinoline (DPD, deoxypyridinoline).
Note the absence of Glc-Gal-PYD in (A): When present, Gal-PYD
elutes as a partially resolved peak 0.5 min later than Glc-Gal-PYD.496 The American Journal of Human Genetics 83, 495–503, Octobewere reduced with myopia (right 2/0.75 3 90, left
2.25/0.503 180). Eye abnormalities were shallow ante-
rior chambers, ﬂat retinae, andcataracts requiring surgery at
age 7 of the patient. Skin, hair, and nail abnormalities all
presented in the ﬁrst year of her life. Skin creases on both
palms were reduced (Figure 2D). Blistering affecting all
toes and ﬁngers and blistering of the pinnae was present
(Figure 2D). This healed without scarring. A skin biopsy
taken outside the blistered areas was normal on light mi-
croscopy. The skin appeared to be thin and poorly perfused
butwith no signiﬁcant abnormalities of healing or scarring.
Hair was described as coarse in texture and rapidly growing
with an unusual distribution (thick over the vertex and
sparse at the hairline). All nails were hypoplastic, although
the small, dysplastic ﬁngernails were described as ‘‘rapidly-
growing with brittle tips’’ (Figure 2E). Teeth were normal.
Bruising occurred readily but prothrombin and partial
thromboplastin times and platelet counts were all found
to be normal. In the second decade, spontaneous vascular
ruptures occurred. At the time when the patient was
11 years old, a spontaneous cerebral arterial haemorrhage
presented with hemiplegia. A large hematoma that was
present in the white matter of the left cerebral hemisphere
and involved both limbs of the internal capsule and basal
ganglia was demonstrated by computed tomography (CT).
A spontaneous rupture of a right popliteal aneurysm (dem-
onstrated by CT angiography, Figure 2F) presented with
pain and swelling. A subsequent CT scan when the patient
was 14 years of age demonstrated gross dilatation of both
internal carotids (Figure 2G). Development was globally
delayed. She walked independently at 4 years of age. Com-
munication was by sign language (Makaton and British
Sign Language) that, by the time that the patient was
16 years old, was used to communicate basic needs and to
ask simple questions. Social skills were also delayed and
joint contractures impeded development of ﬁne motor
skills. Chromosomes showed a normal female pattern,
46,XX, with no evidence of mosaicism. Asymmetry of
the palate raised the possibility of mosaicism; however,
skin chromosomes were normal in 98/100 cells with
a marker chromosome of unidentiﬁed origin in 2/100 cells
representing possible culture artifact.
One male sibling was stillborn at 28 weeks’ gestation.
Intrauterine growth retardation complicated pregnancy.
He had a pointed chin and small, round, low-set ears
(Figure 3A). His middle ﬁngers were long and ﬂexed with
the index ﬁnger overlapping (Figure 3B). Toe nails were
hypoplastic. Autopsy revealed a porencephalic cyst with
dilatation of the cerebral ventricles. Extensive petechial
haemorrhages were seen on the skin. Chromosomes
showed a normal male pattern, 46,XY, in cultured ﬁbro-
blasts from a postmortem biopsy.
The ﬁrst direct evidence that LH3 may be responsible
for the disorder came from measurements indicating
markedly reduced values of GGT activity in the proband’s
serum (Figure 4A) and in lymphoblastoid cells (Figure 4B)
compared to controls. Western analysis revealed a lowr 10, 2008
Figure 2. Clinical Findings of the Proband
(A) Patient at 1 month of age shows a short, upturned nose, long philtrum, and downturned angles of the mouth.
(B) Patient at 3 years of age shows protruding, simple pinnae, and flexion contractures of both elbows and all interphalangeal joints.
(C) Lateral photograph of a patient at age 14 years showing shallow orbits, flat facial profile, short nose with anteverted nares and
low-set, simple ear.
(D) Palmar aspect of the right hand shows superficial peeling of the skin overlying the fourth and fifth middle phalanges (1 year).
(E) By age 14 of the patient, palmar skin shows reduced creases and all fingernails show evidence of progressive atrophy, unrelated to
blistering.
(F) CT angiogram showing aneurysmal dilatation of arteries.
(G) Popliteal angiogram demonstrates aneurysmal dilatation of left popliteal vessels. Informed consent was obtained from the family
involved in this study.concentration of LH3 protein in lymphoblastoid cells com-
pared to control cells (Figure 4C). In order to see possible
mutations in LH3, total RNA was isolated from Epstein-
Barr virus-immortalized lymphoblastoid cells of the pro-
band. cDNA was synthesized with Dynabeads (Dynal) pu-
riﬁed mRNA as a template in oligo(dT)-primed synthesis.
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The PCR ampliﬁed fragments of the cDNAwere used for di-
rect sequencing. LH3 cDNA (NM_001084.4) analysis (Fig-
ures 5A and 5B) revealed two heterozygous changes in
the coding nucleotide sequence: one nucleotide transition
c.668A/G (mutation 1) resulting in the amino acid substi-
tution, p.Asn223Ser, and one nucleotide deletion c.2071
delT (mutation 2) causing a translational frameshift and
generating a premature translational stop codon in the
sequence (p.Cys691AlafsX9). The protein product result-
ing from mutation 2 consists of 698 amino acids, with
Cys691 being the ﬁrst changed amino acid. The premature
termination does not make nonsense-mediated decay
Figure 3. Fetal Photos
Postmortem photographs of stillborn fetus
(A), showing a large cranial vault caused
by cerebral ventricular dilatation. The
male fetus is small for gestational age,
with a short, upturned nose and extensive
petechial skin haemorrhages, although
delivery was not traumatic (that may re-
flect vascular fragility). (B) shows the right
hand with flexion contractures of proximal
interphalangeal joint, worst on the middle
finger.
operative because the allele product
could be seen in lymphoblastoid cells
of the patient after digestion of cDNA
fragments with the NarI restriction
enzyme used to indicate deletion of
the T in the cDNA sequence (data not shown, see also
Figure 5D). This mutated allele produced a protein that
was truncated by 40 amino acids and that deviated from
the LH3 sequence by the eight terminal amino acids at
the C-terminal end of the molecule. Both of the mutations
are located in conserved regions of the LH3 amino acid
sequence, and as indicated earlier,3,6–8 they are located in
the regions responsible for glycosyltransferase and lysyl
hydroxylase activities, respectively (Figure 6). Further-
more, Asn223 is highly conserved among species. Both
nucleotide changes generated a new restriction site to the
nucleotide sequence of PLOD3, so that restriction analysisFigure 4. GGT Activity and LH3 Protein Level of the Proband
GGT activity in proband’s serum (A) and in lymphoblastoid cells (B). The activity in the cells is expressed per mg soluble protein and com-
pared with a mean value of two control cell lines. The activity in serum is expressed per ml serum and compared with a mean value of five
control sera. The SD is indicated by the bars. LH3 protein level was analyzed by western-blot analysis (C) from lymphoblastoid cells of the
patient (P) and from three control lymphoblastoid cells (C1-C3). A total of 2 mg soluble protein from lymphoblastoid cells was pulled
down with Concanavalin A-sepharose (GE Healthcare) and applied to the lanes. Molecular-weight markers are indicated. A GGT activity
assay was performed as described elsewhere.28 The proteins were fractionated under reducing conditions by 7.5% SDS-PAGE, transferred
onto an Immobilon-P membrane (Millipore), and incubated with a polyclonal PLOD3 antibody (Proteintech Group). Anti-rabbit-IgG-HRP
(P.A.R.I.S biotech) was used for secondary detection with ECLþ system (GE Healthcare) and Biomax XAR X-ray film (Kodak).
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Figure 5. Mutation Analysis of LH3
Sequence analysis of LH3 cDNA of the patient revealed a heterozygous nucleotide transition c.668A/G (arrow in [A]) generating amino
acid change p.Asn223Ser in the sequence (mutation 1), and a heterozygous one nucleotide deletion c.2071 delT (arrow in [B]) causing
p.Cys691AlafsX9 frameshift in the amino acid sequence (mutation 2). We used digestion of PCR amplified DNA fragment by restriction
enzymes to screen the mutations in DNA of parents. We used oligonucleotides (A20 50-aagagagagaaaagtgagaaat-30 and A15 50-tgtgcaa
cagatgccagac-30) from introns 5 and 6 to screen mutation 1. Oligonucleotides (A7 50-gagcagcgagagcctcctac-30 and A1 50-actgtctccagct
caggcaat-30) from intron 17 and 30 downstream region of PLOD3 were employed for identification of mutation 2. Digestion of genomic DNA
fragment by BbvCI (NEB) (C) or NarI (NEB) (D) and analysis of the fragments by agarose gel after ethidium bromide staining indicated that
the mutation 1 was inherited from the father and mutation 2 was inherited from the mother. DNA markers are indicated (bp). C, control; P,
patient; M, mother; F, father.could be utilized as the basis for a carrier test for themother
and father. Our restriction analysis indicated that muta-
tion 1 was inherited from the father and mutation 2 was
inherited from the mother (Figures 5C and 5D).
To ascertain the consequences of these mutations on
LH3 activities, we used in vitro mutagenesis with the
QuickChange II site-directed mutagenesis kit (Stratagene)
to generate mutation 1 and mutation 2 in LH3 cDNA
and to produce corresponding recombinant proteins in
Sf9 insect cells. The production of recombinant proteins
was followed by western-blot analysis, and the recombi-
nant LH3 was analyzed in LH, GT, and GGTactivity assays.
The recombinant protein with mutation 1 resulted in
a higher apparent molecular mass for most molecules com-
pared to that for the wild-type LH3 (Figure 7A), a difference
that was not observed when the recombinant proteins
were treated with EndoH for removal of asparagine-linkedThe Americoligosaccharides before western-blot analysis (Figure 7B).
These data suggested that mutation 1 is generating a new
glycosylation site for LH3 at Asn221; this generation
would have been predicted because the amino acid substi-
tution p.Asn223Ser changes Asn-x-Asn to Asn-x-Ser, the
latter being a well-known Asn-linked glycosylation motif
of proteins.19 This abnormality in glycosylation does not,
however, affect the LH3 glucosyltransferase activity
(Figure 7C) and therefore does not explain reduction of
GGT activity of the patient. There was also a mobility shift
in the apparent molecular mass of the recombinant pro-
tein with mutation 2 (Figure 7A), with a 40 amino acid
deletion being clearly observed in the western blot. Our
enzyme activity assays (Figure 8) indicated that mutation
1 reduced substantially the GT and GGT activities of LH3,
and it also reduced the LH activity to approximately half
of the normal level. Mutation 2 resulted in complete lossan Journal of Human Genetics 83, 495–503, October 10, 2008 499
Figure 6. Domain Representation of Human LH3
(A) Putative N-terminal ER signal sequence (ER,
amino acids 1–24) is followed by glycosyltransferase
(GT/GGT) domain (25–280), which is responsible for
GT/GGT activities and has structural similarities with
glycosyltransferases.3 Lysyl hydroxylase/prolyl 4-hy-
droxylase (PKHD) domain (565–738) shares homol-
ogy with 2-oxoglutarate-dependent dioxygenases
and includes a 2-oxoglutarate and ironII-dependent
oxygenase domain. Domain borders are approximated
by sequence comparisons. Amino acids that are
important for activity are indicated in the corre-
sponding domain. DxD motif is a typical domain of
glycosyltransferases and is also crucial for LH3 activ-
ity. LH3mut1 (B) is a protein produced by mutation 1
(c.668A/G) resulting p.Asn223Ser amino acid
substitution. LH3mut2 (C) is a result of mutation 2
(c.2071 delT), in which one nucleotide deletion
causes a frameshift and premature stop-codon forma-
tion (p.Cys691AlafsX9). The size of a LH3mut2
protein is 698 amino acids. The asterisk represents
the last eight amino acids of LH3mut2 differing
from LH3 as a result of frameshift and premature
stop codon formation.of the LH activity for LH3, as well as reduced its GT and
GGT activities. As seen in the lymphoblastoid cells of the
patient (Figure 4C), the amount of LH3 was decreased in
cells, thereby leading to a phenotype that exhibited low
LH3 content and in which the LH3 has markedly reduced
lysyl hydroxylase and glycosyltransferase activities com-
pared to normal. On the basis of results obtained from
mouse studies,9,17 it seems probable that phenotypic
Figure 7. LH3 with Mutation 1 or Mutation 2 Produced in Insect Cells
(A) Immunoblot analysis of recombinant LH3, LH3mut1, and LH3mut2, stained with c-myc antibody.
(B) Immunoblot of EndoH-treated (1 hr at 37C with 50 U EndoH from NEB) LH3 and LH3mut1 shows removal of asparagine-linked
oligosaccrarides, seen as a mobility shift of the bands.
(C) Removal of N-linked glycans by Endo H has no effect on GGT activity of LH3mut1. We used 10 mg soluble protein of insect cell
supernatant in the analysis. GGT activity result is a mean value of four independent experiments; SD is indicated by the bars. Expression
of human LH3 cDNA was carried out in baculovirus transfer vector pFastBacI in the BAC-TO-BAC (Invitrogen) expression system.29 cDNA
(coding amino acids 25–738) of LH3 was inserted to the vector in-frame downstream from ER signal sequence from LH1 and c-myc epitope
tag. Insect cells were harvested 72 hr after infection and homogenized into a solution containing 0.1 M glycine, 1% Igepal CA-630
(Sigma), and 20 mM Tris-HCl (pH 7.4). The homogenate was sonicated and then centrifuged at 15,000 3 g for 20 min and the soluble
fraction was used for western-blot analysis. Proteins were transferred from SDS-PAGE gel to Hybond-LFP (GE Healthcare) PVDF membrane.
Anti c-myc antibody 9E10 (Santa Cruz) and anti-mouse-IgG-AlexaFluor488 (Molecular Probes) were used with Typhoon 9400 (GE Health-
care) for fluorescence detection.
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consequences are mainly resulting from decreased glyco-
syltransferase function and to a lesser extent from de-
creased LH function. Complete loss of GT/GGT function
is lethal in mouse,9 suggesting that complete loss of GT/
GGT activities would be lethal also in humans.
As shown in our LH3-knockout studies,9 it was the GGT
activity of LH3 and not its LH activity that is important for
embryonal development. Lack of the GGT activity causes
embryonic lethality, and with higher GGT activity the
embryos survived longer and had less severe defects than
knockout embryos. Skin blisters and dilatation of blood
vessels were present, and the lethality was probably a con-
sequence of the endothelial cell-layer ruptures and haemo-
rrhage often seen in the embryos. This paper describes
a severe phenotype of PLOD3mutations in man. Intrauter-
ine death of an affected male could have been the result of
cerebral vascular rupture, as suggested by the large poren-
cephalic cyst found at autopsy. His surviving sister
(proband) is severely disabled, with clinical signs of several
discrete conditions that are normally caused by mutations
in genes encoding different types of collagen. No tissue
samples for further collagen studies were available, but
an interesting comparison can be made on clinical
Figure 8. Enzyme Activity Analysis of Recombinant LH3 with
and without Mutation 1 or Mutation 2
The 15,0003 g supernatant of insect cell homogenate was used for
activity assays. LH, GT, and GGT activities were assayed,28 and an
amount of LH3 protein was measured with monoclonal anti c-myc
antibody 9E10 (Santa Cruz), anti-mouse-IgG-AlexaFluor488 (Mo-
lecular Probes) and Typhoon 9400 (GE Healthcare) for fluorescence
detection of immunoblot analysis. Quantification of immuno-
stained LH3 protein levels was performed with ImageQuant TL
7.0 software, GE Healthcare. Relative specific activities of muta-
tion 1 (LH3mut1) and mutation 2 (LH3mut2) were calculated
and compared to activities of nonmutated LH3. The data show
dramatic reduction of glycosyltransferase activities of LH3mut1
and LH activity of LH3mut2. Activities are expressed as the
percentage from activity of nonmutated LH3. n ¼ 4 independent
measurements, except n ¼ 3 in GT of LH3mut1. The SD indicated
by the bars. The asterisk represents activity below detection range.The Americgrounds. Similarities between her phenotype and Stickler
syndrome20 (MIM 108300 and MIM 604841) were noted
(Table 1) at an early age. The ﬂat facial proﬁle and myopia
together with the prominent knee joints would be consis-
tent with this diagnosis. Profound sensorial deafness is
a feature of Stickler syndrome type II (MIM 604841). By
contrast, growth retardation, nail and skin abnormalities,
osteopenia, joint contractures, and spontaneous vascular
rupture are not seen in Stickler syndrome. Spontaneous
vascular rupture is a feature of Ehlers-Danlos syndrome
type IV (EDS IV [MIM 130050]),21 a disorder of type III col-
lagen characterized by thin skin with easy bruising and
talipes (all clinical features seen in the patient). Arterial
rupture and osteopenia are both features of EDS VI (MIM
225400),21 whereas other major features of this disease,
namely joint laxity, congenital scoliosis, scleral fragility,
and the characteristic facial appearance, were absent in
this patient. Although osteopenia is a feature of EDS VI,
caused by PLOD1 mutations, associated fractures are
more in keeping with Bruck syndrome (MIM 609220),
caused by PLOD2 mutations (see also Table 1). Rather
than joint laxity, contractures that fall within the spectrum
of disease seen in patients with EDS VI and Bruck syn-
drome are observed. We used imaging to investigate our
patient’s clinical symptoms and found arterial dilation in
the regions of previous vascular rupture (Figures 2F and
2G). The anatomy of other large vessels has not been stud-
ied. Abnormalities in the ratio of urinary pyridinoline and
deoxypyridinoline crosslinks characteristic of EDS VI were
also absent. Urinary Glc-Gal-pyridinoline has been sug-
gested as a speciﬁc marker of synovial tissue breakdown
in arthritic diseases,22 but other studies indicate that this
component is derived primarily from bone degradation.23
The association of joint contractures and fractures is seen
in Bruck syndrome.14 None of the potential diagnoses
discussed, however, can explain all features of the present
Table 1. Clinical Symptoms of PLOD3 Mutations
Clinical Symptom
Other Collagen Disorder
with Common Feature Mutated Gene
Flat facial profile Stickler syndrome COL2A1, COL11A1,
and COL11A2
Deafness Stickler syndrome COL2A1, COL11A1,
and COL11A2
Myopia Stickler syndrome COL2A1, COL11A1,
and COL11A2
Prominent knee joint Stickler syndrome COL2A1, COL11A1,
and COL11A2
Arterial rupture EDSIV COL3A1
Arterial rupture EDSVI PLOD1
Osteopenia EDSVI PLOD1
Osteopenia Bruck syndrome PLOD2
Joint contractures
and fractures
Bruck syndrome PLOD2
Skin blistering Epidermolysis bullosa COL7A1 and COL17A1
Cataract Stickler syndrome COL2A1, COL11A1,
and COL11A2
Nail abnormalities Epidermolysis bullosa COL7A1an Journal of Human Genetics 83, 495–503, October 10, 2008 501
case, and other phenotypic characteristics, some unique
such as skin blistering, are not associated with any of the
conditions discussed so far. The skin blistering that
occurred from infancy to approximately 5 years of age oc-
curred over areas exposed to friction, ﬂexor aspects of the
ﬁngers and the pinnae. There was some resemblance to
the dystrophic type of epidermolysis bullosa (MIM
131750),24 some types of which are caused by mutations
in collagen genes. Nail abnormalities are also similar to
those that can be seen in epidermolysis bullosa (MIM
131750). Developmental delay is not a feature of the colla-
gen disorders summarized in Table 1. Although multiple
sensory impairments and limitation of physical mobility
caused by joint contractures make accurate development
assessment challenging, the patient has some degree of
global developmental delay.
There is some overlap of clinical feature with the re-
cently described Spondylocheiro dysplastic form of
EDS.25 Childrenwith this recessive condition showed post-
natal growth retardation, whereas PLOD3 mutations
caused prenatal and postnatal growth retardation. Hand
appearances are similar with small joint contractures and
marked thenar and hypothenar muscle wasting in both
conditions. Broad large joints and thin skin with poor
healing and easy bruising are also similar. Osteopenia
and talipes equinovarus are described in both conditions.
Important differences are the absence of severe myopia,
cataracts, deafness, skin blistering, progressive scoliosis, ar-
terial rupture, and fractures in the Spondylocheiro dysplas-
tic form of EDS, in which survival into the third decade is
described. Unlike other types of EDS, which are caused by
mutations in collagen or PLOD genes, mutations in the
zinc-transporter gene SLC39A13 are causative. These are
postulated to interfere with hydroxylation of lysyl and
prolyl residues.
In summary, our data establish a syndrome of congenital
malformations severely affecting many tissues and organs
and revealing features of several collagen disorders, most of
them involving type II collagen. The ﬁndings suggest that
the failure of lysyl hydroxylation and hydroxylysyl carbo-
hydrate addition, which affects many collagens, is the mo-
lecular basis of this syndrome. No similar cases have been
identiﬁed in literature searches. To our knowledge, this is
the ﬁrst inherited syndrome in which mutations are local-
ized in the PLOD3 gene. The small nucleotide changes in
PLOD3 result in amino acid changes in the LH3 polypep-
tide chain localized in regions responsible for LH3 glyco-
syltransferase and lysyl hydroxylase activities, respectively.
The consequences of these mutations to LH3 enzyme
activities and protein levels are dramatic, leading to a phe-
notype in which LH3 concentration is low and all LH3 ac-
tivities, LH, GT, and GGT, are remarkably reduced. Because
of its apparent pleiotropic effects, LH3 aberrations may in
fact contribute more commonly to connective tissue disor-
ders than what is currently recognized. Measurements of
serum GGT activity or urinary collagen crosslink patterns
now provide tools for detecting such disorders.502 The American Journal of Human Genetics 83, 495–503, OctoberAcknowledgments
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